WGHB News By: Marilyn Schairer & Michael Agnello Researchers at Boston’s Beth Israel Deaconess Medical Center have made some promising advances in developing a vaccine to halt the spread of […]
Nature World News By Jean Raphael Two new vaccines against Zika virus have proven its effectiveness in preclinical trials involving mice challenged with Zika virus, suggesting that Zika vaccines for […]
by Loren Grush
CNBC Healthcare, June 29th, 2016
The vaccines still need to go through human clinical trials.
NBC News by MAGGIE FOX A batch of new studies show the Zika virus is trickier than it appeared at first glance, lurking for months in pregnant females and interfering […]
Heard on All Things Considered MICHAELEEN DOUCLEFF This summer, it’s not just athletes who are looking to set world records. Scientists are also trying to break a record — for […]
WCVB5 ABC Virus delared global health emergency A vaccine to protect against the Zika virus is in the works under a research team led by scientists at the Beth Israel […]
WBUR By Jonathan Cain “We hope that this news will electrify and galvanize the vaccine effort against Zika virus,” says Dr. Dan Barouch of Beth Israel Deaconess Medical Center and […]
The Boston Herald Lindsay Kalter A group of researchers at Beth Israel Deaconess Medical Center are testing a vaccine for the Zika virus they say has exceeded expectations in animal […]
- By: Andrew Joseph @DrewQJoseph
Two new experimental vaccines protect mice against the Zika virus, a study out Tuesday shows.
Researchers from governments, academic labs, and biopharma companies have been rushing to develop Zika vaccines since global health experts started warningabout the previously unknown dangers wrought by the mosquito-borne virus, including serious birth defects. Just last week, the Food and Drug Administration approved the first human testing of a Zika vaccine candidate from the company Inovio Pharmaceuticals.
Sorry, no posts matched your criteria
Center for Virology and Vaccine Research
3 Blackfan Circle
Boston, MA 02115 – USA
CVVR Clinical Trials Unit